Where to invest $10,000 into ASX shares in September

Analysts reckon these stocks could be great destinations for your hard earned money.

| More on:
Man holding fifty Australian Dollar banknote in his hands, symbolising dividends, symbolising dividends.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are lucky enough to have $10,000 burning a hole in your pocket, then it could be worth putting it to work in the share market.

But which ASX shares would be good options for this sort of investment when the market reopens? Let's take at a look at three picks for investors to consider:

CSL Ltd (ASX: CSL)

The first ASX share that could be a top option for a $10,000 investment is biotherapeutics giant CSL.

Analysts at Bell Potter remains very positive on the company due to its attractive valuation and positive earnings growth outlook. It said:

CSL presents an attractive buying opportunity as we anticipate the start of a margin recovery phase for CSL, driving above-market earnings growth over the next few years. CSL trades at a 12-month forward PE of ~31x, representing a discount to its 5 year average of ~35x. Furthermore, the company will continue to deleverage the balance sheet over the next few years. Given the company's proven quality and growth prospects, we believe significant upside remains.

The broker has a buy rating and $316.50 price target on its shares. It is also worth noting that analysts at Macquarie believe CSL's shares could rise beyond $500 in the coming years if it delivers on its expectations.

Megaport Ltd (ASX: MP1)

Another ASX share that could be a quality pick for investors next week is Megaport. It is a network as a service provider that has been growing at a rapid rate for a number of years.

Goldman Sachs believes that a pullback last month has created a buying opportunity for investors. Particularly given its significant long-term growth runway. It commented:

[W]e remain confident MP1 has a clear product advantage vs. peers and a decade-long runway for robust growth. Despite the soft operational trends in recent periods, we expect still robust top-line growth, with the increased focus on profitable growth supporting an attractive earnings profile over FY24-26.

Goldman Sachs has a buy rating and $12.00 price target on its shares.

Origin Energy Ltd (ASX: ORG)

A third ASX share that could be a top option for a $10,000 investment is Origin Energy.

That's the view of analysts at Goldman Sachs, which are also feeling positive about this energy giant.

Goldman likes Origin for a number of reasons. This includes its APLNG business, attractive yields, and investment in Octopus. It explains:

We expect electricity markets will remain volatile where ~50% of FY25E EBITDA from APLNG should reduce risk, while supporting a strong 6% dividend yield. […] ORG operates the National Electricity Market's (NEM) largest gas generation fleet at 3 GW which will become increasingly important to firm renewable generation, while maintaining a A$10/GJ cost of gas supply which should support margin expansion or market share gain. […] Octopus' valuation has already increased 600% since ORG's initial investment in 2020, which we expect could continue to grow over 20% in FY25 as contracted Kraken accounts growth drives 30% EBITDA growth.

The broker has a buy rating and $10.75 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, Macquarie Group, and Megaport. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Broker Notes

Where to invest $10,000 in ASX 200 shares this month

Brokers think these shares could be top picks for your hard-earned money this month.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise 40%+

Big returns could be on offer from these shares according to analysts.

Read more »